CDC’s latest RSV shot guidance for older adults, explained

CDC now recommends one RSV dose for adults 75 and older, and for adults 50 to 74 who are at increased risk of severe RSV illness. Here’s what changed, who may qualify, when vaccination makes the most sense, and what has not changed.

CDC’s adult RSV guidance is now narrower and more specific than it was when RSV vaccines first became available. For many older adults, the main point is straightforward: the recommendation is for a single dose, not an annual shot.

That matters because RSV can cause serious illness in older adults, but CDC does not recommend the vaccine for every person in the 50-to-74 age range. The key question this season is whether you are in the group CDC says should be vaccinated, and whether now is the right time to ask about it.

Who CDC says should get an RSV vaccine

According to CDC, RSV vaccination is recommended for adults ages 75 and older and for adults ages 50 to 74 who are at increased risk of severe RSV illness. CDC says the higher-risk 50-to-74 group includes adults with certain chronic medical conditions and other risk factors that raise the chance of severe disease.

In plain language, the guidance is aimed at older adults whose age, health conditions, or other risk factors make an RSV infection more likely to lead to complications or hospitalization. If you think you may qualify, CDC’s current clinical guidance is the place to check the specific risk factors.

Why timing matters

CDC says eligible adults can get an RSV vaccine at any time, but the best window is late summer or early fall, before RSV usually starts spreading more widely. That timing is meant to help people build protection before the season picks up.

If you are eligible and have not yet been vaccinated, it is reasonable to bring it up with a clinician or pharmacist before respiratory virus season is underway.

What has not changed

The RSV vaccine is not currently an annual vaccine. CDC says people who have already received one dose have completed their vaccination and should not receive another dose at this time.

CDC and FDA continue to monitor safety after licensing. In CDC’s safety information and post-licensure tracking, the vaccine is described as under ongoing surveillance in older adults, with the overall recommendation remaining in place for people who meet the current eligibility criteria.

Why uptake still matters

Even with a clear recommendation, many eligible older adults still had not gotten the vaccine as of CDC’s recent surveillance. CDC’s RSVVaxView dashboard and a recent journal study both suggest that coverage remains incomplete, which means many people who could benefit may still be unprotected.

That gap matters for families, caregivers, and community settings because RSV spreads easily and can be especially hard on older adults and people with certain medical conditions.

What to ask a clinician or pharmacist

If you think you may qualify, ask whether you are in the recommended group for a one-time RSV dose. It can also help to ask:

  • whether your age and health conditions fit CDC’s current guidance;
  • when the best time is to get the vaccine based on local RSV season timing;
  • whether it can be given at the same visit as other adult vaccines, since short-term side effects such as a sore arm, fever, headache, or body aches can happen after vaccination.

If you are unsure whether a condition counts as higher risk, ask the clinician to check CDC’s current clinical guidance rather than guessing based on age alone.

Bottom line

CDC’s current RSV guidance for older adults is more targeted than a broad one-size-fits-all message. The main takeaway is that adults 75 and older, and adults 50 to 74 at increased risk of severe RSV illness, should review whether they qualify for a one-time RSV vaccine before the season starts. If you are not sure where you fit, the safest next step is to ask a clinician or pharmacist to check your eligibility against CDC guidance.

Sources

Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.

This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.